VI-003

N/A

Report date: 2025/01/26 17:46:50

Base Information

Drug NameVI-003
Drug Alias Namecytokine-based therapeutics (VivImmune)VI-003
ClassificationBiologics
Mechanisms of ActionCytokine receptors agonists
TargetsCytokine receptorsInterleukin 18 receptor
Therapy Area/IndicationsUrinary Bladder NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivImmune LLC
China Registration ClassN/A

Develop Information

Active CompaniesVivImmune LLC
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A